Last reviewed · How we verify
Td Vaccine
At a glance
| Generic name | Td Vaccine |
|---|---|
| Also known as | Tetanus and Diphtheria Toxoids Adsorbed |
| Sponsor | Baylor College of Medicine |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma (PHASE1, PHASE2)
- Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (PHASE3)
- ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients (PHASE1)
- Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae (PHASE2)
- Long-Term PF-06651600 for the Treatment of Alopecia Areata (PHASE3)
- Immunosuppression and COVID-19 Boosters (PHASE3)
- Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas (PHASE1)
- PFAS Exposure and Immune Response to Vaccination in Adults (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |